CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research

CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research


's stock had its "buy" rating reissued by Zacks Investment Research in a research note issued on Sunday, MarketBeat Ratings reports. They currently have a $20.00 price target on the stock.



from Biotech News